Erschienen in:
01.12.2008 | Brief Report
Induction potential of clavulanic acid toward L1 and L2 β-lactamases of Stenotrophomonas maltophilia
verfasst von:
C.-W. Lin, R.-M. Hu, S.-C. Huang, Y.-J. Hsiao, T.-C. Yang
Erschienen in:
European Journal of Clinical Microbiology & Infectious Diseases
|
Ausgabe 12/2008
Einloggen, um Zugang zu erhalten
Excerpt
Clavulanic acid is firstly noticed for its potent inhibitory activity against plasmid-mediated β-lactamases among gram-negative organisms [
1]. Plasmid-mediated β-lactamases, which belong to Bush groups 2a, 2b, 2c, or 2d, are generally constitutively expressed in microorganisms [
2]. In clinical practice, the combination of β-lactam and clavulanic acid has been proposed to be an effective treatment for bacterial infections. Clavulanic acid is also recognized as a potential inducer for chromosomal AmpC β-lactamases (Bush group 1/Amber C) of the family
Enterobacteriaceae [
3,
4] and
Pseudomonas aeruginosa [
5]. And, more importantly, clavulanate is not an efficient inhibitor to β-lactamases of Bush group 1.
Stenotrophomonas maltophilia owns two chromosomal-medicated inducible β-lactamases, L1 and L2, which belong, respectively, to Bush group 3c/Amber B and Bush group 2e/Amber A [
2]. Clavulanic acid is known to be the most potent inhibitor against the L2 activity [
6]. In contrast, clavulanate shows no inhibition effect on the activity of L1 β-lactamase [
7]. …